Business
Mesoblast share price on the rise after delivering promising FY20 results – Motley Fool Australia
The Mesoblast share price is on the rise this morning after the company delivered positive FY20 results and sets itself up for FY21.
The share price of ASX junior biotechnology company Mesoblast Limited (ASX:MSB) is on the move after the company released its FY20 results to the market Thursday morning. At the time of writing, the Mesoblast share price had risen 3.69% to $5.34.
What’s moving the Mesoblast share price?
The Mesoblast share price has been boosted after the company reported a 92% increase in revenues to US$32.2 million, while its loss after tax decreased by 13% year on year to US$77.9 million. Despite posting a …
-
Noosa News18 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General10 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging
-
Noosa News17 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050